Study of BEBT-109 in Subjects With Non-Small Cell Lung Cancer Carrying EGFR Exon 20 Insertion Mutations

NCT06514027 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: BEBT-109 Capsules
DRUG: Pemetrexed Disodium for Injection
DRUG: Carboplatin Injection
DRUG: Cisplatin Injection

Sponsor

BeBetter Med Inc